$303.69
1.05%
NYSE, Sep 28, 04:00 pm EDT. Closed.
ISIN
US03073E1055
Symbol
COR

Cencora Stock News

Neutral
●
Business Wire
●
4 days ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026. Mr. Sanchez is the Executive Chair of Ryder System, Inc., where he previously served as Chair and Chief Executive Officer until his retirement in March 2026. Prior to being appointed CEO in 2013, Mr. San...
Neutral
●
Business Wire
●
27 days ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora today launched a service to help health systems evaluate, build and scale cell and gene therapy (CGT) programs. Offered through Accelerate Pharmacy Solutions, Cell and Gene Therapy Enablement is designed to help health systems strengthen operational readiness and program execution to reduce barriers to care and expand patient access to advanced therap...
Positive
●
Reuters
●
about 2 months ago
U.S. drug distributor Cencora raised its annual adjusted profit forecast on Wednesday after quarterly results beat ​Wall Street expectations, driven by strong demand ‌for specialty medicines.
Neutral
●
Business Wire
●
about 2 months ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026 third quarter ended June 30, 2026, revenue increased 5.1 percent year-over-year to $84.8 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.94 for the third quarter of fiscal 2026 compared to $3.52 in the prior year third quarter...
Negative
●
Reuters
●
about 2 months ago
The U.S. Federal Trade Commission is taking ​a closer look at a proposed $3.5 ‌billion acquisition that would combine two of the leading national suppliers of veterinary ​products, Cencora's MWI Animal Health ​and privately held Covetrus, Bloomberg News ⁠reported on Tuesday.
Neutral
●
Barrons
●
3 months ago
These stocks can hold their ground, or even gain, when the market falls. And a garden variety correction—a 10% drop or more—is quite possible.
Neutral
●
Business Wire
●
3 months ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced a multi-site pilot of its enhanced Nucleus® inventory management solution, designed to help specialty physician practices manage increasingly complex medication workflows with greater efficiency, visibility and control. Developed with input from customer advisory boards and specialty care pro...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today